Literature DB >> 9864164

Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival.

M P Scheid1, I N Foltz, P R Young, J W Schrader, V Duronio.   

Abstract

The role of ceramide as a second messenger is a subject of great interest, particularly since it is implicated in signaling in response to inflammatory cytokines. Ceramide induces apoptosis in both cytokine-dependent MC/9 cells and factor-independent U937 cells. Elevation of cyclic adenosine monophosphate (cAMP) levels inhibits apoptosis induced by ceramide and several other treatments. One target of cAMP-mediated signaling is the transcription factor CREB (cAMP response element binding protein), and recently CREB phosphorylation at an activating site has been shown to also be mediated by a cascade involving p38 mitogen-activated protein kinase (MAPK), one of the stress-activated MAP kinases. Because no role for p38 MAPK in apoptosis has been firmly established, we examined the relationship between p38 MAPK and CREB phosphorylation under various conditions. Ceramide, or sphingomyelinase, like tumor necrosis factor- (TNF-) or the hematopoietic growth factor, interleukin-3 (IL-3), was shown to activate p38 MAPK, which in turn activated MAPKAP kinase-2. Each of these treatments led to phosphorylation of CREB (and the related factor ATF-1). A selective p38 MAPK inhibitor, SB203580, blocked TNF-- or ceramide-induced CREB phosphorylation, but had no effect on the induction of apoptosis mediated by these agents. The protective agents cAMP and IL-3 also led to CREB phosphorylation, but this effect was independent of p38 MAPK, even though IL-3 was shown to activate both p38 MAPK and MAPKAP kinase-2. Therefore, the opposing effects on apoptosis observed with cAMP and IL-3, compared with ceramide and TNF-, could not be explained on the basis of phosphorylation of CREB. In addition, because SB203580 had no effect of TNF- or ceramide-induced apoptosis, our results strongly argue against a role for p38 MAPK in the induction of TNF-- or ceramide-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864164

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Attenuation of macrophage apoptosis by the cAMP-signaling system.

Authors:  A von Knethen; B Brüne
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 3.  Recent advances in the immunobiology of ceramide.

Authors:  Saumya Pandey; Richard F Murphy; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2006-10-12       Impact factor: 3.362

4.  CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.

Authors:  W Chen; Y L Yu; S F Lee; Y J Chiang; J R Chao; J H Huang; J H Chiong; C J Huang; M Z Lai; H F Yang-Yen; J J Yen
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

5.  Effect of procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3.

Authors:  Gergana Deevska; Manjula Sunkara; Claudia Karakashian; Benjamin Peppers; Andrew J Morris; Mariana N Nikolova-Karakashian
Journal:  J Lipid Res       Date:  2014-07-21       Impact factor: 5.922

6.  The inhibitory effect of dibutyryl cyclic AMP on docosahexaenoic acid-induced apoptosis in HL-60 cells through activation of the phosphatidylinositol-3 kinase pathway.

Authors:  Yoshie Miura; Yoshiyuki Murata; Kozo Utsumi; Kyoya Takahata; Mikiro Tada; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2005-07       Impact factor: 3.674

7.  CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy.

Authors:  Kathleen M Sakamoto; David A Frank
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

8.  Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis.

Authors:  Z F Yu; M Nikolova-Karakashian; D Zhou; G Cheng; E H Schuchman; M P Mattson
Journal:  J Mol Neurosci       Date:  2000-10       Impact factor: 2.866

Review 9.  A tale of two proteins: PACT and PKR and their roles in inflammation.

Authors:  Evelyn Chukwurah; Kenneth T Farabaugh; Bo-Jhih Guan; Parameswaran Ramakrishnan; Maria Hatzoglou
Journal:  FEBS J       Date:  2021-01-15       Impact factor: 5.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.